A double-blinded, placebo-controlled randomized trial evaluating the efficacy and safety of Zhigancao Tang granules for treating HFpEF: study protocol for a randomized controlled trial

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterized by diastolic dysfunction. Despite the increasing incidence of HFpEF, there is no available therapy that reduces the mortality rate of HFpEF. Zhigancao Tang has been used traditionally for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Na, Zhao, Yingli, Liu, Yu, Tang, Nuo, Zheng, Wang, Mao, Meijiao, Liu, Qingcheng, Shen, Lin, Deng, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056488/
https://www.ncbi.nlm.nih.gov/pubmed/33879223
http://dx.doi.org/10.1186/s13063-021-05232-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056488/
https://www.ncbi.nlm.nih.gov/pubmed/33879223
http://dx.doi.org/10.1186/s13063-021-05232-6

Ejemplares similares